OncoMatch/Clinical Trials/NCT05943119
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Is NCT05943119 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies non-drug interventions for tumor, solid.
The patient is randomized to one of the following groups: * Experimental group: Radiotherapy in painting dose on histoscannographic mapping * Control group: standard pan-sinus radiotherapy
Check if I qualifyExtracted eligibility criteria
Prior therapy
Must have received: endoscopic sinonasal surgery
Cannot have received: neoadjuvant chemotherapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT05943119 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior neoadjuvant chemotherapy disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify